A prospective observational study on the usefulness of effect site concentrations of remimazolam during general anesthesia

A prospective observational study on the usefulness of effect site concentrations of remimazolam during general anesthesia - usefulness of effect site concentrations of remimazolam

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000057220

Enrollment

Registered

2025-03-10

Start date

2025-03-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult patients scheduled to undergo general anesthesia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who have given their written consent of their own free will after being fully explained about the research.

Exclusion criteria

Exclusion criteria: 1) Patients with ASA (American Society of Anesthesiologists) classification III or higher 2) Patients aged 80 years or older 3) Patients with a history of neurological disease 4) Patients who regularly take benzodiazepine sleeping pills before surgery 5) Patients who the principal investigator or sub-investigator deems unsuitable for this clinical trial

Design outcomes

Primary

Measure	Time frame
Effect site concentration of remimazolam when patient loses response and regains consciousnes	—

Secondary

Measure	Time frame
Relationship between EEG (BIS value) and effect site concentration of remimazolam	—

Countries

Japan

Contacts

Public ContactTomoyuki Oka

Ube Central Hospital Department of Pharmacy

Tomoyuki.oka@ube-hp.or.jp0836519221

Outcome results